Showing 1 - 20 results of 34 for search 'Patrick Terheyden', query time: 0.48s Refine Results
  1. 1
    Ring‐shaped plaque on the face
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The impact of the Covid-19 pandemic on quality of life in skin cancer patients.
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Primary Cutaneous Gamma-Delta T-Cell Lymphoma With Long-Term Indolent Clinical Course Initially Mimicking Lupus Erythematosus Profundus
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort studyResearch in context
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort studyResearch in context
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma
    Article
    Save to List
    Saved in:
  18. 18
    Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma
    Get full text
    Article
    Save to List
    Saved in:
Search Tools: RSS Feed – Email Search